Corrigendum to "Discovery of analogues of non-β oxidizable long-chain dicarboxylic fatty acids as dual inhibitors of fatty acids and cholesterol synthesis: Efficacy of lead compound in hyperlipidemic hamsters reveals novel mechanism" [Nutr Metabol Cardiovasc Dis 31 (2021) 2490-2703]

Nutr Metab Cardiovasc Dis. 2022 Jan;32(1):290-293. doi: 10.1016/j.numecd.2021.10.002. Epub 2021 Dec 8.

¹ Integrated Pharma Solutions, Andover, MA, USA. Electronic address: [email protected].
² Ferndale Laboratories, Ann Arbor, MI, USA.
³ Creative Pharma Advisors, Gainesville, FL, USA.
⁴ University of Toronto, Toronto, Canada.
⁵ Espervita Therapeutics Inc, Ann Arbor, MI, USA.

No abstract available

Publication types